Synopsis
Synopsis
0
USDMF
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Benzoylmetronidazole
2. Benzoylmetronidazole Monohydrate
3. Klion Suspension
1. 13182-89-3
2. Benzoyl Metronidazole
3. Benzoylmetronidazole
4. 2-(2-methyl-5-nitro-1h-imidazol-1-yl)ethyl Benzoate
5. Klion Suspension
6. 2-(2-methyl-5-nitroimidazol-1-yl)ethyl Benzoate
7. 2-methyl-5-nitro-1h-imidazole-1-ethyl Benzoate
8. Chebi:50688
9. A355c835xc
10. 1h-imidazole-1-ethanol, 2-methyl-5-nitro-, 1-benzoate
11. Flagyl S
12. Unii-a355c835xc
13. Metronidazole Benzoate [usp:ban]
14. Einecs 236-131-7
15. Metronidazoli Benzoas
16. Elyzol (tn)
17. Benzoylmetronildazole;
18. Oprea1_489419
19. Metronidazole Benzoate (usp)
20. Mls000590415
21. Schembl366213
22. Chembl1466172
23. Dtxsid60157221
24. Hms2569a06
25. Zinc163922
26. Bcp28722
27. Mfcd00693654
28. S5863
29. Akos015888108
30. Metronidazole Benzoate [mart.]
31. Ab06961
32. Ccg-253836
33. Metronidazole Benzoate [usp-rs]
34. Metronidazole Benzoate [who-dd]
35. Metronidazole Benzoate [who-ip]
36. Ncgc00160502-01
37. Ac-14443
38. Ac-33577
39. As-13537
40. Smr000217345
41. Db-042064
42. Hy-122975
43. Metronidazole Benzoate;benzoyl Metronidazole
44. Cs-0090787
45. Ft-0628935
46. Metronidazole Benzoate [ep Monograph]
47. Metronidazoli Benzoas [who-ip Latin]
48. Metronidazole Benzoate [usp Monograph]
49. C90395
50. D08214
51. 2-(2-methyl-5-nitro-1-imidazolyl)ethyl Benzoate
52. 5-nitro-2-methyl-1-(2-benzoyloxyethyl)-imidazole
53. A806316
54. 2-(2-methyl-5-nitro-imidazol-1-yl)ethyl Benzoate
55. Q12199321
56. Benzoic Acid 2-(2-methyl-5-nitro-1-imidazolyl)ethyl Ester
57. Benzoic Acid 2-(2-methyl-5-nitro-imidazol-1-yl)-ethyl Ester
58. Metronidazole Benzoate; 2-(2-methyl-5-nitro-1h-imidazol-1-yl)ethyl Benzoate
| Molecular Weight | 275.26 g/mol |
|---|---|
| Molecular Formula | C13H13N3O4 |
| XLogP3 | 2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 275.09060590 g/mol |
| Monoisotopic Mass | 275.09060590 g/mol |
| Topological Polar Surface Area | 89.9 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 352 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
13
PharmaCompass offers a list of Metronidazole Benzoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Metronidazole Benzoate manufacturer or Metronidazole Benzoate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Metronidazole Benzoate manufacturer or Metronidazole Benzoate supplier.
PharmaCompass also assists you with knowing the Metronidazole Benzoate API Price utilized in the formulation of products. Metronidazole Benzoate API Price is not always fixed or binding as the Metronidazole Benzoate Price is obtained through a variety of data sources. The Metronidazole Benzoate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A benzoylmetronidazole monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of benzoylmetronidazole monohydrate, including repackagers and relabelers. The FDA regulates benzoylmetronidazole monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. benzoylmetronidazole monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of benzoylmetronidazole monohydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A benzoylmetronidazole monohydrate supplier is an individual or a company that provides benzoylmetronidazole monohydrate active pharmaceutical ingredient (API) or benzoylmetronidazole monohydrate finished formulations upon request. The benzoylmetronidazole monohydrate suppliers may include benzoylmetronidazole monohydrate API manufacturers, exporters, distributors and traders.
click here to find a list of benzoylmetronidazole monohydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a benzoylmetronidazole monohydrate Drug Master File in Korea (benzoylmetronidazole monohydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of benzoylmetronidazole monohydrate. The MFDS reviews the benzoylmetronidazole monohydrate KDMF as part of the drug registration process and uses the information provided in the benzoylmetronidazole monohydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a benzoylmetronidazole monohydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their benzoylmetronidazole monohydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of benzoylmetronidazole monohydrate suppliers with KDMF on PharmaCompass.
A benzoylmetronidazole monohydrate CEP of the European Pharmacopoeia monograph is often referred to as a benzoylmetronidazole monohydrate Certificate of Suitability (COS). The purpose of a benzoylmetronidazole monohydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of benzoylmetronidazole monohydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of benzoylmetronidazole monohydrate to their clients by showing that a benzoylmetronidazole monohydrate CEP has been issued for it. The manufacturer submits a benzoylmetronidazole monohydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a benzoylmetronidazole monohydrate CEP holder for the record. Additionally, the data presented in the benzoylmetronidazole monohydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the benzoylmetronidazole monohydrate DMF.
A benzoylmetronidazole monohydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. benzoylmetronidazole monohydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of benzoylmetronidazole monohydrate suppliers with CEP (COS) on PharmaCompass.
A benzoylmetronidazole monohydrate written confirmation (benzoylmetronidazole monohydrate WC) is an official document issued by a regulatory agency to a benzoylmetronidazole monohydrate manufacturer, verifying that the manufacturing facility of a benzoylmetronidazole monohydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting benzoylmetronidazole monohydrate APIs or benzoylmetronidazole monohydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a benzoylmetronidazole monohydrate WC (written confirmation) as part of the regulatory process.
click here to find a list of benzoylmetronidazole monohydrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing benzoylmetronidazole monohydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for benzoylmetronidazole monohydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture benzoylmetronidazole monohydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain benzoylmetronidazole monohydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a benzoylmetronidazole monohydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of benzoylmetronidazole monohydrate suppliers with NDC on PharmaCompass.
benzoylmetronidazole monohydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of benzoylmetronidazole monohydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right benzoylmetronidazole monohydrate GMP manufacturer or benzoylmetronidazole monohydrate GMP API supplier for your needs.
A benzoylmetronidazole monohydrate CoA (Certificate of Analysis) is a formal document that attests to benzoylmetronidazole monohydrate's compliance with benzoylmetronidazole monohydrate specifications and serves as a tool for batch-level quality control.
benzoylmetronidazole monohydrate CoA mostly includes findings from lab analyses of a specific batch. For each benzoylmetronidazole monohydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
benzoylmetronidazole monohydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (benzoylmetronidazole monohydrate EP), benzoylmetronidazole monohydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (benzoylmetronidazole monohydrate USP).
